How can Burden of Disease (BoD) measures that were used in the pandemic help in Examining European Health Inequalities (BoD-EEHI)? Towards better harmonisation, better data, better analyses

This report helps us look into several issues of importance to ASPHER. Firstly, we wished to identify which Burden of Disease (BoD) methods and metrics have been used in understanding the pandemic so far. Secondly, we wished to examine how BoD is usually measured and what are the strengths and weaknesses of the various metrics/methods. Thirdly, we also are interested in how BoD tools were applied during the COVID-19 pandemic and what initial studies tell us for European populations and vulnerable groups and how BoD evidence can inform us to help with assessing and reducing pandemic health inequalities and promoting equity. Finally, we also
consider how BoD approaches might develop in future and what are ASPHER’s priorities and recommendations to our members and to our partners, including further developing necessary teaching concepts and public health workforce competencies.